1. Home
  2. PLSM vs HIND Comparison

PLSM vs HIND Comparison

Compare PLSM & HIND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pulsenmore Ltd. Ordinary Shares

PLSM

Pulsenmore Ltd. Ordinary Shares

HOLD

Current Price

$1.40

Market Cap

11.6M

Sector

Health Care

ML Signal

HOLD

Logo Vyome Holdings Inc.

HIND

Vyome Holdings Inc.

SELL

Current Price

$1.24

Market Cap

11.1M

Sector

N/A

ML Signal

SELL

Company Overview

Basic Information
Metric
PLSM
HIND
Founded
2014
2017
Country
Israel
United States
Employees
N/A
2
Industry
Medical/Dental Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.6M
11.1M
IPO Year
2025
2016

Fundamental Metrics

Financial Performance
Metric
PLSM
HIND
Price
$1.40
$1.24
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
★ $8.83
AVG Volume (30 Days)
★ 12.6K
11.3K
Earning Date
08-31-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 64.86
EPS
★ N/A
N/A
Revenue
N/A
★ $319,714.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$145.24
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 24.43
52 Week Low
$1.27
$1.45
52 Week High
$12.97
$5.88

Technical Indicators

Market Signals
Indicator
PLSM
HIND
Relative Strength Index (RSI) 28.23 18.42
Support Level N/A N/A
Resistance Level $2.64 $2.31
Average True Range (ATR) 0.12 0.10
MACD 0.00 -0.02
Stochastic Oscillator 4.65 4.58

Price Performance

Historical Comparison
PLSM
HIND

About PLSM Pulsenmore Ltd. Ordinary Shares

Pulsenmore Ltd is an emerging medical device company engaged in the research, development, manufacturing, marketing, and sale of non-invasive portable ultrasound solutions for home use. Its products include the Pulsenmore ES and Pulsenmore FC, along with the early-stage Pulsenmore MC, collectively referred to as Pulsenmore Products, enabling remote ultrasound scans in gynecology and other fields such as pulmonary, cardiology, and urology through telemedicine. The Company operates in a single segment focused on developing and commercializing portable ultrasound technologies, with Israel contributing the majority of its revenue.

About HIND Vyome Holdings Inc.

Vyome Holdings Inc is a clinical-stage specialty pharmaceutical company working to treat immune-inflammatory and rare diseases of unmet need with next-generation therapeutic solutions. Its product candidates are: VT-1953, a topical gel that is being developed to treat signs and symptoms of malignant fungating wounds in cancer; VT-1908, a repurposed immune modulator to treat steroid-sparing anterior uveitis; and VB1953, which is being developed to treat moderate to severe acne. Vyome has also commercialized two novel reformulated topical anti-fungal products based on the technology platform of Molecular Replacement Therapeutics (MRT) in India: a dandruff lotion and shampoo. It operates in two segments: pharmaceutical products, which generate the maximum revenue, and biotechnology.

Share on Social Networks: